12/19/2024
3:10 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
4:03 PM | Aptose Biosciences (Filer)
| Form PRE 14A | |
12/12/2024
9:30 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
11:05 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
5:56 PM | Aptose Biosciences (Issuer)
Rice William G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:27 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2024
5:05 AM | Aptose Biosciences (Filer)
| Form 424B4 | |
|
11/22/2024
7:05 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
11:15 PM | Aptose Biosciences (Filer)
| Form EFFECT | |
11/20/2024
7:00 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
2:22 PM | Aptose Biosciences (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
10/31/2024
5:39 AM | Aptose Biosciences (Filer)
| Form S-1/A | |
10/04/2024
3:15 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
3:15 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:20 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:35 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
3:35 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:15 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:22 PM | Aptose Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
8:43 PM | Aptose Biosciences (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/26/2024
3:30 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
4:00 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
10:43 AM | Aptose Biosciences (Filer)
| Form DEF 14A | |
07/05/2024
9:19 AM | Aptose Biosciences (Filer)
| Form PRE 14A | |
06/14/2024
6:40 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
3:35 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
9:32 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
5:05 AM | Aptose Biosciences (Filer)
| Form 424B5 | |
05/31/2024
7:05 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
10:47 AM | Aptose Biosciences (Filer)
| Form DEF 14A | |
05/10/2024
10:35 AM | Aptose Biosciences (Issuer)
LEDRU PHILIPPE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:45 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
3:30 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
4:21 PM | Aptose Biosciences (Filer)
| Form PRE 14A | |
04/29/2024
4:19 PM | Aptose Biosciences (Filer)
| Form 10-K/A | |
04/26/2024
11:54 AM | Aptose Biosciences (Subject)
Hanmi Pharmaceutical Co., Ltd. (Filed by)
| Form SC 13D/A | |
04/26/2024
6:30 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
4:05 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
4:00 PM | Aptose Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:04 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
4:45 PM | Aptose Biosciences (Issuer)
Bejar Rafael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Why I'm telling friends to avoid gold stocks (Ad) Back in November, gold made a tiny move of 1.6%.
But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week.
It happened again in March. Gold nudged up 1.2%.
This time? A 104% overnight gain.
And in June? A 1% gold move turned into a 74% gain in two weeks.
Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now.
There's a more lucrative way to play the gold market as we enter a new breakout period.
It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. |
02/07/2024
5:06 PM | Aptose Biosciences (Issuer)
Payne Fletcher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
4:26 PM | Aptose Biosciences (Issuer)
LEDRU PHILIPPE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
8:44 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2024
4:30 PM | Aptose Biosciences (Filer)
| Form 424B4 | |
01/26/2024
7:00 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
11:15 PM | Aptose Biosciences (Filer)
| Form EFFECT | |
01/25/2024
8:44 PM | Aptose Biosciences (Filer)
| Form S-1MEF | |
01/19/2024
8:50 PM | Aptose Biosciences (Filer)
| Form S-1/A | |
12/29/2023
3:10 PM | Aptose Biosciences (Filer)
| Form S-1/A | |
